Qingyu Xu

1PUBLICATIONS
1CO-AUTHORS
Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 26, 2019
Epigenetic modifier gene mutations-positive AML patients with intermediate-risk karyotypes benefit from decitabine with CAG regimen.

Qingyu Xu, Yan Li, Yu Jing

Pageof 1

Frequent Collaborators

1 joint publications

Yonghui Li